Researchers at the Institute for Bioscience and Biotechnology Research (IBBR) recently received $3.5M from the National Institutes of Health (NIH) to advance understanding of the complex process by which the immune system produces highly specialized antibodies. The goal of the project is to design and test novel vaccine candidates that improve the protective antibody response against HIV-1. IBBR Fellow Dr. Yuxing Li (Associate Professor, Department of Microbiology and Immunology, University of Maryland School of Medicine) is principal investigator on the award.
{iframe}https://www.prnewswire.com/news-releases/ibbr-investigator-to-lead-3-5m-nih-funded-project-to-study-immune-response-to-hiv-1–300838380.html{/iframe}